A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran.
Zerehsaz
F
F
Shiraz Clinic and Department of Dermatology, Shiraz University of Medical Sciences, Iran.
Salmanpour
R
R
Handjani
F
F
Ardehali
S
S
Panjehshahin
M R
MR
Tabei
S Z
SZ
Tabatabaee
H R
HR
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D007492:Iran; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008536:Meglumine / Q000008:administration & dosage*; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage*; D010936:Plant Extracts / Q000008:administration & dosage*; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D010936:Plant Extracts; D008536:Meglumine; D000077485:Meglumine Antimoniate